EN DE

ASP Isotopes Inc. Common Stock (ASPI) Fair Value & Analysis

Basic Materials · US · Market cap $841M · ISIN US00218A1051

What is ASP Isotopes Inc. Common Stock really worth?

AI ASP Isotopes Inc. Common Stock logo ASP Isotopes Inc. Common Stock ASPI · US
Price$4.20
Fair Value$0.7100
Upside−83.1%
Quality17/100

Below-average quality, and trading another 492% above our fair value of $0.7100.

As of Aug 14, 2026, the fair value of ASP Isotopes Inc. Common Stock is $0.7100 per share against a price of $4.20, so the fair value sits 83% below the price. A model estimate blended from multiple valuation models, recalculated regularly.

Watch ASP Isotopes Inc. Common Stock for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free

Risks

!Mixed Growth (revenue YoY +475.5 %/yr)
!Thin margins · 0.0% net margin
!negative free cash flow
!Trails peers (1/8)
!Narrow moat 14/100
!Evidence only low, so the estimate is less certain
Evidence: Low Range $0.4700 – $0.8900

Fair value as of: Aug 14, 2026

From 1 valuation models · updated 23 days ago

Share price +3.7% over the past month.

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

What matters now

  • The price sits above even our optimistic bull case ($0.8900). The favourable scenario is already priced in.
  • Weak quality (17/100) and above fair value at the same time, the margin of safety is missing on both counts.
  • The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
  • A fairly wide model range ($0.4700 to $0.8900) leaves room in how you read the outcome.

Price vs Fair Value (4 years)

$14.05 $0.3200 Fair Value $0.7100 Nov 2022 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 14, 2026.

How to read this chart

46‑month range $0.3200 – $14.05 · fair‑value band $0.4700 – $0.8900 · the $4.20 price screens above the $0.7100 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 14, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

ASP Isotopes Inc. Common Stock (ASPI) currently trades at $4.20, while our model-based Fair Value estimate is $0.7100, implying the stock looks roughly 491.7% overvalued today. The Quality Score stands at 17/100 (below-average quality), in the Basic Materials sector. How firm this estimate is: it rests on 1 models at a data quality of 80/100, which puts the evidence level at low.

Trailing-twelve-month revenue stands at $26.9M. Revenue grew 279.3% year over year. The balance sheet holds a net cash position of $69.6M. Fundamentals as of Aug 14, 2026

Our scenario range runs from $0.4700 (bear case) to $0.8900 (bull case); at $4.20, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 71% below its 52-week high and 7% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at −48% fair-value upside, at −83%, ASPI screens richer than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
NCAV (Graham) best evidence $0.8100 $1.09 $1.62 51
All 1 models by family
Asset-Based
NCAV (Graham) best evidence $0.8100 $1.09 $1.62 51

Notify me when ASPI reaches fair value

Put ASPI on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Free, no payment details. Unsubscribe anytime in one click.

Key figures & financial health

P/S ratio 31.2 TTM
EPS (TTM) $−2.21
Return on equity −103% TTM
Return on assets (EBIT) −33.9% avg 5y
Operating margin −595% TTM
Revenue (TTM) $26.9M TTM
More key figures
Growth
Revenue growth (YoY) +279%
Balance sheet & cash flow
Free cash flow −$47.4M FY2025
Net cash $69.6M FY2025

Figures from reported company fundamentals · as of Aug 14, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 17/100

Of which business quality 23 · Market factors (momentum, volatility) 2

Profitability 0
Margins and returns on capital today
Quality Growth 61
Are margins and returns improving?
Cashflow 0
Earnings quality: real cash, not paper profit
Fin. Strength 74
Balance sheet, leverage, solvency risk
Investment 0
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 3
Price trend over the last 3–12 months (market factor)
52W Momentum 1
Distance to the 52-week high (market factor)
Net Issuance 0
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.

About the company

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services.

Full company description

ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment engages in the research and development of technologies and methods used to separate high-value, low-volume isotopes, such as C-14, Mo-100 and Si-28, for target end markets, including pharmaceuticals and agrochemicals, nuclear medical imaging, and semiconductors; provision of related services; and operation of PET labs. The company offers the Aerodynamic Separation Process (ASP) technology, which separates gas species and isotopes in a volatile state; and the Quantum Enrichment (QE) technology, which separates isotopes. It also produces and commercializes Molybdenum-100, Molybdenum-98, and Ytterbium-176 for the nuclear medical industry. In addition, the company develops Zinc-68, Nickel-64, and Xenon-129/136 for the nuclear medical industry; Lithium-7, Uranium-235, and Chlorine-37 for the energy industry; and Germanium-70/72/74 for semiconductor markets. The company was incorporated in 2021 and is based in Dallas, Texas.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2019 – FY2025 · reported fiscal years

ASP Isotopes Inc. Common Stock reported revenue of $23.8M in FY2025 versus $22.6M in FY2019, a compound +0.9%/yr. Reported net income was −$175M in FY2025.

Growth Quality 28/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Latest Revenue (FY 2025)
$23.8M
Latest YoY
+475.5%
Avg. revenue growth/yr (6Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+0.9%
EBIT margin (trend) Operating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−45.3% (2019) → −239.8% (2025)
Value creation/yr We only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Revenue +0.9%/yr
FY19 $22.6M
FY22 $0
FY23 $433K
FY24 $4.1M
FY25 $23.8M
Net income
FY21 −$2.6M
FY22 −$4.9M
FY23 −$16.3M
FY24 −$32.3M
FY25 −$175M

ASPI screens 492% overvalued. Compare with Saudi Basic Industries Corporation →

Share or link this analysis
𝕏 Post WhatsApp LinkedIn Reddit
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "ASP Isotopes Inc. Common Stock Fair Value". https://www.fairvalue-calculator.com/stock/ASPI.US

Peer Group

Chemicals · 340 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 24 · Bottom 25%
Fair Value upside −83% · Bottom 25%
Return on assets −14% · Bottom 25%
Net margin (TTM) 0% · Below median
Revenue growth 279% · Top 25%

Valuation Multiples vs Chemicals median · lower = cheaper

P/B 4.12× · Pricier than 75% of peers
P/S (TTM) 31.23× · Pricier than 75% of peers

Strength profile in five axes (Snowflake)

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE0 · sector 0
FUTURE100 · sector 22
PAST0 · sector 20
HEALTH0 · sector 94
DIVIDEND0 · sector 32

VALUE 0: the price sits above our fair-value range.

Insider activity: 42/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Chemicals stocks, each showing price versus our Fair Value estimate (as of Aug 14, 2026).

Stock Price Fair Value vs Fair Value
Saudi Basic Industries Corporation 2010 49.50 SAR 18.13 SAR −63%
A. Schulman, Inc SLMNP $849.00 $203.64 −76%
Ningxia Baofeng Energy Group 600989 ¥24.49 ¥20.17 −18%
Dow Inc DOW $30.51 $21.03 −31%
Zhejiang Juhua Co 600160 ¥41.32 ¥21.62 −48%
Rongsheng Petrochemical Co 002493 ¥13.76 ¥2.39 −83%
Zangge Mining Company 000408 ¥78.04 ¥20.99 −73%
PT Barito Pacific Tbk, BRPT 1,855 IDR 1,584 IDR −15%
Ganfeng Lithium Group 002460 ¥52.53 ¥16.17 −69%
Hengli Petrochemical Co 600346 ¥18.87 ¥17.09 −9%

Compare ASP Isotopes Inc. Common Stock with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screener Filter by region, size and sector Compare tool Two stocks side by side Extrinsic Value Calculator (Options) Splits an option premium into intrinsic and extrinsic (time) value. Peter Lynch Fair Value Formula & Calculator Apply Peter Lynch's fair value formula in seconds: fair P/E ≈ earnings growth (+ dividend) - free, with formula and example.

Frequently asked questions

Is ASP Isotopes Inc. Common Stock (ASPI) overvalued or undervalued?
As of Aug 14, 2026, our model estimates a fair value of $0.7100 versus a price of $4.20, about −83% upside (overvalued).
What is the fair value of ASPI?
Our model-based fair value for ASP Isotopes Inc. Common Stock is $0.7100 (as of Aug 14, 2026), built from audited fundamentals. The current price: $4.20.
What is the quality score of ASPI?
ASP Isotopes Inc. Common Stock has a Quality Score of 17/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for ASP Isotopes Inc. Common Stock (ASPI)?
Our model-based price target is the fair value of $0.7100 (as of Aug 14, 2026) from 1 valuation models. Cautious scenario $0.4700, optimistic scenario $0.8900. It is a calculation from audited fundamentals, not an analyst target.
What is the ASP Isotopes Inc. Common Stock stock forecast for 2026?
Our models put fair value at $0.7100, about −83% upside versus a price of $4.20 (overvalued). Cautious scenario $0.4700, optimistic scenario $0.8900. The calculation is refreshed regularly with new filings.
What is the revenue of ASP Isotopes Inc. Common Stock (ASPI)?
ASP Isotopes Inc. Common Stock reported trailing-twelve-month revenue of about $26.9M (latest available figure, as of Aug 14, 2026).
What is the net profit margin of ASPI?
The net profit margin of ASP Isotopes Inc. Common Stock is about 0.0%, meaning it keeps roughly 0.0% of revenue as net income. Based on the latest reported figures.
Free · no account needed

Watch ASP Isotopes Inc. Common Stock in the live analysis

One click puts ASP Isotopes Inc. Common Stock on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.